Some panel members noted that,in practice, granulocyte colony-stimulating factor (G-CSF) isoften given concomitantly at the start of Len/Dex therapy orvery soon after treatment initiation, and felt that a short courseof G-CSF (3 days) should be considered in certain cases,such as for patients with increased bone marrow infiltration.48This may be particularly valuable in patients who havefailed oth